1
Published 2017
Canadian Agency for Drugs and Technologies in Health
... as an antagonist. This property distinguishes it from morphine. It has high affinity for mu opioid receptors...

2
Published 2015
Canadian Agency for Drugs and Technologies in Health
...Requiring tamper-resistant properties for products that contain particular controlled substances...

3
Published 2015
Canadian Agency for Drugs and Technologies in Health
...Requiring tamper-resistant properties for products that contain particular controlled substances...

4
Published 2014
Canadian Agency for Drugs and Technologies in Health
... with mild OSA due to its anti-inflammatory properties. The purpose of this review is to examine the clinical...

5
Published 2014
Canadian Agency for Drugs and Technologies in Health
... with mild OSA due to its anti-inflammatory properties. The purpose of this review is to examine the clinical...

6
Published 2013
Canadian Agency for Drugs and Technologies in Health
...Naloxone is an opioid antagonist without agonist properties. In opioid-dependent patients, naloxone...

7
Published 2014
Canadian Agency for Drugs and Technologies in Health
... in kinematic and biomechanical properties across device designs, choice of an artificial disc represents a...

8
Published 2014
Canadian Agency for Drugs and Technologies in Health
... in kinematic and biomechanical properties across device designs, choice of an artificial disc represents a...

9
by Chao, Yi-Sheng, McCormack, Suzanne
Published 2019
Canadian Agency for Drugs and Technologies in Health
... to have no psychoactive properties. In addition, there are two synthetical cannabinoids approved...

10
Published 2017
Canadian Agency for Drugs and Technologies in Health
... Pediatric) are detrusor relaxant drugs with antimuscarinic and calcium-modulating properties indicated...

11
by Chao, Yi-Sheng, McCormack, Suzanne
Published 2019
Canadian Agency for Drugs and Technologies in Health
... to have no psychoactive properties. In addition, there are two synthetical cannabinoids approved...

12
by Brett, Kendra, Argáez, Charlene
Published 2019
Canadian Agency for Drugs and Technologies in Health
... antiseptic and disinfectant properties, triclosan is used in numerous products, including personal care...

13
by Brett, Kendra, Argáez, Charlene
Published 2019
Canadian Agency for Drugs and Technologies in Health
... antiseptic and disinfectant properties, triclosan is used in numerous products, including personal care...

14
Published 2017
Canadian Agency for Drugs and Technologies in Health
...-inflammatory properties, although the precise mechanism of action is not known. The oral and rectal...

15
Published 2017
Canadian Agency for Drugs and Technologies in Health
...-inflammatory properties, although the precise mechanism of action is not known. The oral and rectal...

16
Published 2015
Canadian Agency for Drugs and Technologies in Health
... of damaged teeth. PFM crowns have good mechanical properties, satisfactory esthetic results...

17
Published 2015
Canadian Agency for Drugs and Technologies in Health
... of damaged teeth. PFM crowns have good mechanical properties, satisfactory esthetic results...

18
by Wells, Charlotte, Loshak, Hannah, Dulong, Camille
Published 2019
Canadian Agency for Drugs and Technologies in Health
... methamphetamine, which, despite being classified as a stimulant, is a drug with different properties than other...

19
by Wells, Charlotte, Loshak, Hannah, Dulong, Camille
Published 2019
Canadian Agency for Drugs and Technologies in Health
... methamphetamine, which, despite being classified as a stimulant, is a drug with different properties than other...

20
Published 2014
Canadian Agency for Drugs and Technologies in Health
... attributed to factors other than chemotherapy. In addition, the appetite stimulating properties...